An Exercise Intervention for Prostate Cancer Patients Receiving Androgen Deprivation Therapy
Completed · Not applicable
Conditions studied: Prostate Cancer, Physical Activity, Side-effects
In brief
This main purpose of this study is to examine the effects of an exercise intervention to counteract adverse side effects related to Androgen Deprivation Therapy (ADT) in prostate cancer patients. Specifically, a supervised and home-based exercise program will be used to assess its impact on clinical and behavioral variables related to ADT in prostate cancer patients.
Key facts
- Study ID
- NCT02248350
- Run by
- Georgetown University
- People needed
- 19
- Starts
- 2014-09-01
- Expected to finish
- 2017-09-01
- Last updated by the study team
- 2018-02-15
Who can join
Age: 40 and older, up to 70. Sex: male. Healthy volunteers: not accepted.
You may qualify if…
- (1) Caucasian or African-American/Black men; (2) histologically confirmed non-metastatic PCa; (3) receiving ADT treatment for 9-months or less upon recruitment (and continue to receive treatment during the duration of the study); (4) 40 to 75 years old; (5) sedentary defined as <60 minutes of recreation or work requiring modest PA/week; (6) ability to perform the level of physical activity assessed by the Physical Activity Readiness Questionnaire (PAR-Q); (6) has access to a smartphone or computer with internet capabilities
You may not qualify if…
- (1) severe cardiac disease; (2) recent myocardial infarction; (3) treated for any other cancer; (4) any physical, psychological illness, and/or medical problems that restricted them from exercise; (5) and not willing or able to follow procedures specified by the study and/or instructions of the researcher.
Where it is running
- Office of Minority Health and Health Disparities Research — Washington D.C., District of Columbia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.